"Hormones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
| Descriptor ID |
D006728
|
| MeSH Number(s) |
D06.472 D27.505.696.399.472
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hormones".
Below are MeSH descriptors whose meaning is more specific than "Hormones".
This graph shows the total number of publications written about "Hormones" by people in this website by year, and whether "Hormones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 4 | 0 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 3 | 4 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 5 | 7 |
| 2004 | 2 | 3 | 5 |
| 2005 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 4 | 4 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 2 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 4 | 1 | 5 |
| 2016 | 4 | 2 | 6 |
| 2017 | 4 | 1 | 5 |
| 2018 | 0 | 2 | 2 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 2 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hormones" by people in Profiles.
-
Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine- and enterocyte-derived hormones. FASEB J. 2025 Mar 31; 39(6):e70408.
-
Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration. Ann Behav Med. 2023 11 16; 57(12):1014-1023.
-
Plant (di)terpenoid evolution: from pigments to hormones and beyond. Nat Prod Rep. 2023 02 22; 40(2):452-469.
-
Role of AMPK/mTOR, mitochondria, and ROS in the pathogenesis of endometriosis. Life Sci. 2022 Oct 01; 306:120805.
-
The Impact of Gender-affirming Hormone Therapy on Anatomic Structures of the Brain Among Transgender Individuals. J Psychiatr Pract. 2022 07 01; 28(4):328-334.
-
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2022 05; 23(5):625-635.
-
Anterior pituitary, sex hormones, and keratoconus: Beyond traditional targets. Prog Retin Eye Res. 2022 05; 88:101016.
-
Caudamins, a new subclass of protein hormones. Trends Endocrinol Metab. 2021 12; 32(12):1007-1014.
-
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Cancer Ther. 2021 01; 20(1):11-25.
-
Constitutive expression of progesterone receptor isoforms promotes the development of hormone-dependent ovarian neoplasms. Sci Signal. 2020 10 06; 13(652).